{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:59:00Z","timestamp":1792666740813,"version":"4.5.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T00:00:00Z","timestamp":1330473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0032090","type":"journal-article","created":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T22:11:23Z","timestamp":1330553483000},"page":"e32090","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":131,"title":["Systematic Review and Meta-Analysis of Randomized Clinical Trials in the Treatment of Human Brucellosis"],"prefix":"10.1371","volume":"7","author":[{"given":"Juli\u00e1n","family":"Sol\u00eds Garc\u00eda del Pozo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Solera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,2,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis.","volume":"6","author":"G Pappas","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4269\/ajtmh.2005.73.392","article-title":"Hospital-based surveillance for acute febrile illness in Egypt: A focus on community-acquired bloodstream infections.","volume":"73","author":"S Afifi","year":"2005","journal-title":"Am j Trop Med Hyg"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199607000-00003","article-title":"Complications associated with Brucella melitensis infection: a study of 530 cases.","volume":"75","author":"JD Colmenero","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"ref4","first-page":"1","article-title":"WHO Tech Rep Ser","volume":"740","year":"1986","journal-title":"WHO Tech Rep Ser"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1371\/journal.pmed.0040317","article-title":"Perspectives for the treatment of brucellosis in the 21<sup>st<\/sup> century: The Ioannina recommendations.","volume":"4","author":"J Ariza","year":"2007","journal-title":"PLOS medicine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijantimicag.2005.06.001","article-title":"New approaches to the antibiotic treatment of brucelosis.","volume":"26","author":"G Pappas","year":"2005","journal-title":"Int J Antimicrobial Agents"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/clinids\/12.6.1060","article-title":"Modern chemotherapy for brucellosis in humans.","volume":"12","author":"WH Hall","year":"1990","journal-title":"Rev Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/AAC.28.4.548","article-title":"Comparative trial of rifampin-doxycicline versus tetracycline-streptomycin in the therapy of human brucellosis.","volume":"28","author":"J Ariza","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/infdis\/152.6.1358","article-title":"Comparative trial of cotrimoxazol versus tetracicline-streptomycin in treating human brucellosis.","volume":"152","author":"J Ariza","year":"1985","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jac\/23.3.433","article-title":"Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study.","volume":"23","author":"G Acocella","year":"1989","journal-title":"J Antimicrobial Chemoteraphy"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000238662","article-title":"Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis.","volume":"35","author":"JD Colmenero Castillo","year":"1989","journal-title":"Chemotherapy"},{"key":"ref12","first-page":"731","article-title":"Metaan\u00e1lisis sobre la eficacia de la combinaci\u00f3n de rifampicina y doxiciclina en el tratamiento de la brucelosis humana.","volume":"102","author":"J Solera","year":"1994","journal-title":"Med Clin (Barc)"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/AAC.50.1.22-33.2006","article-title":"Quinolones for treatmentof human brucellosis: critical review of the evidencefrom microbiological and clinical studies.","volume":"50","author":"ME Falagas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"7646","key":"ref14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/bmj.39497.500903.25","article-title":"Treatment of human brucellosis: systematic review and meta-analysis of randomized controlled trials.","volume":"336","author":"K Skalsky","year":"2008","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1179\/joc.2003.15.5.466","article-title":"Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.","volume":"15","author":"Y Bayindir","year":"2003","journal-title":"J Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijid.2005.11.007","article-title":"Comparison between doxycycline-rifampin-amikacin and doxyxycline-rifampin regimens in the treatment of brucelosis.","volume":"11","author":"M Ranjbar","year":"2007","journal-title":"Int J Infect Dis"},{"key":"ref17","first-page":"649","article-title":"Ensayo terap\u00e9utico comparativo y multic\u00e9ntrico de rifampicina y doxiciclina frente a estreptomicina y doxiciclina en la brucelosis humana.","volume":"96","author":"J Solera","year":"1991","journal-title":"Med Clin (Barc)"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-117-1-25","article-title":"Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study.","volume":"117","author":"J Ariza","year":"1992","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.37.9.1831","article-title":"Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.","volume":"37","author":"M Akova","year":"1993","journal-title":"Antimicrob Agents Chemoter"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1128\/AAC.39.9.2061","article-title":"Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis.","volume":"39","author":"J Solera","year":"1995","journal-title":"Antimicrob Agents Chemoter"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s100960050344","article-title":"Ciprofloxacin and rifampin versus doxycycline and rifampin in the treatment of brucelosis.","volume":"18","author":"C Agalar","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2334-4-18","article-title":"Ofloxacin plus rifampin versus doxycycline plus rifampin in the treatment of brucellosis: a randomized clinical trial.","volume":"4","author":"O Karabay","year":"2004","journal-title":"BMC Infectious Diseases"},{"key":"ref23","first-page":"360","article-title":"Comparative study of two regimens in the treatment of brucelosis.","volume":"6","author":"M Rodriguez Zapata","year":"1987","journal-title":"Chemioterapia"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1128\/AAC.34.5.881","article-title":"Multicenter prospective study of treatment of Brucella melitensis brucelosis with doxycycline for 6 weeks plus streptomycin for 2 weeks.","volume":"34","author":"JM Cisneros","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/clind\/16.5.671","article-title":"Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucelosis.","volume":"16","author":"JM Montejo","year":"1993","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1258\/004947505774938765","article-title":"Comparison of three different combination therapies in the treatment of human brucellosis.","volume":"35","author":"Y Ersoy","year":"2005","journal-title":"Trop Doct"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/501359","article-title":"Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.","volume":"42","author":"MR Hasanjani Roushan","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/jac\/dkq064","article-title":"Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial.","volume":"65","author":"MR Hasanjani Roushan","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/AAC.38.12.2798","article-title":"Possible implications of doxycycline-rifampin interaction for treatment of brucelosis.","volume":"38","author":"JD Colmenero","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","first-page":"75","article-title":"A multicenter therapeutic study of 1100 children with brucellosis.","volume":"8","author":"MM Lubani","year":"1989","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/AAC.41.1.80","article-title":"Treatment of human brucellosis with doxycycline and gentamicin.","volume":"41","author":"J Solera","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1086\/426024","article-title":"A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucelosis.","volume":"39","author":"J Solera","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/clinids\/22.3.441","article-title":"Treatment of human brucelosis with netilmicin and doxycicline.","volume":"22","author":"J Solera","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1086\/318503","article-title":"Azithromycin and gentamicin therapy for the treatment of humans with brucellosis.","volume":"32","author":"J Solera","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref35","first-page":"2666","article-title":"Human brucellosis: do we need to revise our therapeutic policy?","volume":"30","author":"YM El Miedani","year":"2003","journal-title":"J Rheumatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0399-077X(96)80077-1","article-title":"Ciprofloxacin plus doxycycline versus rifampicin plus doxycycline in the treatment of acute brucelosis.","volume":"26","author":"T Kalo","year":"1996","journal-title":"M\u00e9d Mal Infect"},{"issue":"8","key":"ref37","first-page":"921","article-title":"Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.","volume":"23","author":"N Saltoglu","year":"2002","journal-title":"Saudi Med J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1258\/td.2009.090030","article-title":"A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline an doxycycline-rifampin in the treatment of brucellosis.","volume":"39","author":"F Keramat","year":"2009","journal-title":"Trop Doct"},{"key":"ref39","first-page":"889","article-title":"Comparison of two chemotherapy regimen: doxycycline-rifampicin and doxycycline cotrimoxazol in the brucellosis patients. Ahvaz, Iran, 2004\u20132006.","volume":"23","author":"SM Alavi","year":"2007","journal-title":"Pak J Med Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1179\/joc.2003.15.3.248","article-title":"Treatment of human brucellosis with rifampin plus minocycline.","volume":"15","author":"A Cascio","year":"2003","journal-title":"J Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jac\/26.6.841","article-title":"Failure of prolongued treatment with ciprofloxacin in acute infections due to Brucella melitensis.","volume":"26","author":"R Lang","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"ref42","first-page":"564","article-title":"Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs co-trimoxazole plus rifampin in brucellosis.","volume":"134","author":"MR Hasanjani Roushan","year":"2004","journal-title":"Swiss med Wkly"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/01.inf.0000219403.91975.ce","article-title":"Efficacy of cotrimoxazole and rifampin for 6\u20138 weeks of therapy in childhood brucellosis.","volume":"25","author":"MR Hasanjani Roushan","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"ref44","article-title":"Doxycycline plus streptomycin versus ciprofloxacin plus rifampin in spinal brucellosis.","author":"E Alp","year":"2006","journal-title":"BMC Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/clinids\/14.2.506","article-title":"Failure of ceftriaxone in the treatment of acute brucellosis.","volume":"14","author":"R Lang","year":"1992","journal-title":"Clin Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1742-1241.1973.tb09081.x","article-title":"A comparative study of therapeutic agents used for treatment of acute brucellosis.","volume":"27","author":"JM Feiz","year":"1973","journal-title":"Br J Clin Pract"},{"key":"ref47","first-page":"1443","article-title":"Su 295 casi di brucellosi trattati con moniciclina.","volume":"78","author":"E Grasso","year":"1987","journal-title":"Min Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0163-4453(05)80021-0","article-title":"Relapse of brucelosis following ofloxacin therapy.","volume":"22","author":"N Khuri-Bulos","year":"1991","journal-title":"J Infect"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF01971279","article-title":"Use of ciprofloxacin in the treatment of brucellosis.","volume":"11","author":"M Doganay","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.36.1.150","article-title":"Efficacy of ciprofloxacin for treatment of Brucella melitensis infections.","volume":"36","author":"MB Al-Sibai","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0163-4453(90)92214-6","article-title":"Diagnosis and treatment of 106 cases of human brucellosis.","volume":"20","author":"A Shehabi","year":"1990","journal-title":"J Infect"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/030006058901700409","article-title":"Ceftriaxone in the treatment of acute and subacute human brucellosis.","volume":"17","author":"HY al-Idrissi","year":"1989","journal-title":"J Int Med Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/AAC.41.7.1621","article-title":"Failure of short antimicrobial treatments for human brucellosis.","volume":"41","author":"O Abramson","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4269\/ajtmh.1998.58.190","article-title":"Early clinical response to different therapeutic regimens for human brucellosis.","volume":"58","author":"GM Malik","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0399-077X(02)00403-1","article-title":"Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients.","volume":"32","author":"B Aygen","year":"2002","journal-title":"M\u00e9d Mal Infect"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0014-2565(02)71152-1","article-title":"Estudio de 1595 casos de brucelosis en la provincia de Almer\u00eda (1972\u20131998) seg\u00fan datos epidemiol\u00f3gicos de declaraci\u00f3n de la enfermedad.","volume":"202","author":"P Barroso Garc\u00eda","year":"2002","journal-title":"Rev Clin Esp"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijid.2006.10.002","article-title":"Brucellosis in 418 patients from the Balkan peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome.","volume":"11","author":"M Bosilkovski","year":"2007","journal-title":"Int J Infect Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/jinf.1999.0586","article-title":"Brucella bacteraemia: clinical and laboratory observations in 160 patients.","volume":"40","author":"Z Memish","year":"2000","journal-title":"J Infect"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijid.2005.10.011","article-title":"Acute brucelosis: presentation, diagnosis, and treatment of 144 cases.","volume":"11","author":"P Andriopoulos","year":"2007","journal-title":"Int J Infect Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1201-9712(02)90108-6","article-title":"Brucellosis in children: clinical observations in 115 cases.","volume":"6","author":"M AlShaalan","year":"2002","journal-title":"Int J Infect Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.idc.0000240863.82188.95","article-title":"Prospective evaluation of 140 patients with brucellosis in the southern region of Turkey.","volume":"15","author":"L Savas","year":"2007","journal-title":"Infect Dis Clin Pract"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1258\/td.2006.006266","article-title":"Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment.","volume":"38","author":"N Demirt\u00fcrk","year":"2008","journal-title":"Trop Doct"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","article-title":"Human brucellosis.","volume":"7","author":"MP Franco","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jinf.2006.09.015","article-title":"Doxycycline-rifampin: physicians&apos; inferior choice in brucelosis or how convenience reigns over science.","volume":"54","author":"G Pappas","year":"2007","journal-title":"J Infect"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/j.ijid.2009.06.031","article-title":"Clinical manifestations and complications in 1028 cases of brucelosis: a retrospective evaluation and review of the literature.","volume":"14","author":"T Buzgan","year":"2010","journal-title":"Int J infect Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0025-7753(02)73409-X","article-title":"Brucelosis en el siglo XXI.","volume":"119","author":"J Ariza","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"ref67","first-page":"447","article-title":"Brucellosis.","volume":"4","author":"TM Straight","year":"2002","journal-title":"Curr Treatment Options Infect Dis"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1517\/13543784.15.10.1141","article-title":"Future trends in human brucellosis treatment.","volume":"15","author":"G Pappas","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1179\/joc.2007.19.3.243","article-title":"Brucellosis in the middle East: a persistent medical, socioeconomic and political issue.","volume":"19","author":"G Pappas","year":"2007","journal-title":"J Chemother"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinids\/20.5.1241","article-title":"Characteristics of and risk factors for relapse of brucelosis in humans.","volume":"20","author":"J Ariza","year":"1995","journal-title":"Clin Infect Dis"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0163-4453(98)93342-4","article-title":"Multivariate model for predicting relapse in human brucellosis.","volume":"36","author":"J Solera","year":"1998","journal-title":"J infect"},{"key":"ref72","article-title":"Medimecum.","author":"LF (coord) Villa","year":"2010"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0032090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T21:10:02Z","timestamp":1687295402000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0032090"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Biondi-Zoccai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,29]]},"references-count":72,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0032090","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,29]]}}}